Living with CKD as a woman of childbearing age without dialysis or transplant

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a qualitative, observational study using Interpretative Phenomenological Analysis (IPA) to explore how young women with CKD perceive and integrate the disease into daily life. Semi-structured interviews are conducted to capture personal meaning, identity, relationships, and future plans. The analysis emphasizes in-depth, case-by-case interpretation before any general conclusions are drawn. The research is conducted at Caen University Hospital to understand the lived experience of CKD in women not yet on dialysis or transplantation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women aged ≥ 18 years, cisgender, and not menopausal
* Patients under follow-up at Caen University Hospital for chronic kidney disease
* Patients not receiving renal replacement therapy (i.e., not on dialysis or kidney transplantation)
* Patients who have been informed about the study and provided consent to participate

Exclusion Criteria:

* Patients not covered by a national health insurance system
* Patients under legal protection (guardianship, curatorship, or legal safeguard)
* Patients with insufficient proficiency in French (spoken and written) to understand study information, participate in the interview, and complete the quality-of-life questionnaire
* Patients unable to attend in-person visits at the Centre Universitaire des Maladies Rénales (CUMR)
* Patients with comorbid conditions other than chronic kidney disease that may interfere with the study objectives (e.g. conditions affecting fertility)

Where it's running

• Centre Universitaire des Maladies Rénales (CUMR), Caen University Hospital
  Caen, France Recruiting

Study contacts

• Principal investigator: Antoine Lanot, MD — University Hospital, Caen
• Study coordinator: Tauc Florence, PharmD candidate
• Email: florence.tauc@etu.unicaen.fr
• Phone: +33682753772

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Clazakizumab for adults with high hsCRP at risk for a heart event

  This study tests whether clazakizumab can lower inflammation and reduce cardiovascular risk in adults with high hsCRP and existing risk factors.

  Recruiting at 32 sites Phase 2 Eli Lilly and Company · Huntsville, Alabama and 45 other locations · NCT07783802

• Balcinrenone plus dapagliflozin vs dapagliflozin alone in CKD stages 3b-4

  This study tests whether balcinrenone combined with dapagliflozin works better than dapagliflozin alone in adults with CKD stage 3b–4.

  Recruiting at 33 sites Phase 3 AstraZeneca · Huntsville, Alabama and 477 other locations · NCT07624305

• Exercise during hemodialysis to prevent muscle loss and improve sleep

  This trial will test if a 12-week supervised exercise program performed during dialysis can improve muscle mass, strength, physical performance, sleep quality, and quality of life for patients aged 40 and over on chronic hemodialysis.

  Recruiting University of Salamanca · Salamanca, Salamanca · NCT07447375

• Home-based exercise to boost fitness for people waiting for a kidney transplant

  This study tests whether a 12-week, home-based exercise program plus a wearable activity tracker helps adults on the kidney transplant waiting list increase daily activity and improve physical function.

  Recruiting University of Pennsylvania · Philadelphia, Pennsylvania · NCT07446296

• Transformative 2.0 for diabetic kidney disease

  This project will try to see if adults with diabetic kidney disease who take SGLT2 diabetes medicines have different biological patterns in archived kidney tissue than similar people who do not take these medicines.

  Recruiting University of Pennsylvania · Philadelphia, Pennsylvania · NCT07444203

• Anrikefen vs Nalfurafine for sleep quality in kidney disease patients with itching

  A randomized, open-label study tests whether the injectable Anrikefen improves sleep better than the oral nalfurafine in adults on hemodialysis with CKD-associated itching.

  Recruiting Phase 4 Zhujiang Hospital · Guangzhou, Guangdong · NCT07380113

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.